Bicalutamide Plus Aromatase Inhibitors in ER(+)/AR(+)/HER2(-) Metastatic Breast Cancer

NCT02910050 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Bicalutamide
DRUG: Aromatase Inhibitor

Sponsor

Xu fei

Collaborators

[object Object]